Print this page South San Francisco, CA — May 18, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have high… Read More »
WEST LAFAYETTE, Ind. – A new tool for medical professionals may help shed more light on tumors in the body and how the brain operates. Purdue University researchers created technology that uses optical imaging to better help surgeons map out tumors in the body and help them understand how certain diseases affect activity in the brain.… Read More »
C and E and the risk of breast cancer: results from a case, can be toxic in tiny doses. Vitamin E supplementation and cardiovascular events in high, skip to site navigation Skip to Content This content does not have an English version. Vitamin E treatment of focal segmental glomerulosclerosis: results of an open — vitamin… Read More »
Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won. The immuno-oncology star trumped various chemo regimens at keeping cancer from progressing in previously untreated patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer that had either spread to other parts of the body or couldn’t be surgically removed,… Read More »